TWD 26.9
(0.94%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 12.28 Million TWD | -20.49% |
2022 | 15.45 Million TWD | 538.29% |
2021 | 2.42 Million TWD | -56.8% |
2020 | 5.6 Million TWD | 1.01% |
2019 | 5.54 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 7.36 Million TWD | -40.02% |
2024 Q2 | 7.36 Million TWD | 45.45% |
2023 FY | 12.28 Million TWD | -20.49% |
2023 Q2 | 13.84 Million TWD | 31.32% |
2023 Q1 | 10.54 Million TWD | -31.79% |
2023 Q4 | 12.28 Million TWD | 36.98% |
2023 Q3 | 8.96 Million TWD | -35.2% |
2022 Q3 | 12.08 Million TWD | 0.0% |
2022 Q4 | 15.45 Million TWD | 27.89% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 113.44 Million TWD | 89.17% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 95.668% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1312.184% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 95.426% |
NaviFUS Corp. | 32.69 Million TWD | 62.42% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -126.22% |
Sinew Pharma Inc. | 6.46 Million TWD | -90.068% |
Lin BioScience, Inc. | 42.87 Million TWD | 71.343% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -949.189% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 2.569% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -788.359% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.949% |
AP Biosciences Inc | 82.07 Million TWD | 85.031% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 92.943% |
RBC Bioscience Corporation | 487.36 Million TWD | 97.479% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.198% |
EirGenix Inc. | 465.16 Million TWD | 97.359% |
Enimmune corporation | 45.73 Million TWD | 73.136% |
Lukas Biomedical Inc. | 82.55 Million TWD | 85.118% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -242.038% |
3D Global Biotech Inc. | 10.37 Million TWD | -18.374% |
TaiMed Biologics Inc. | 750.85 Million TWD | 98.364% |
Mycenax Biotech Inc. | 726.27 Million TWD | 98.308% |
TCI GENE Inc. | 6.79 Million TWD | -80.809% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -481.173% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.913% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -182.177% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -13.78% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 87.32% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -54.134% |
Neith Corporation | 3.54 Million TWD | -246.964% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 96.861% |
VBI | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -108.308% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 95.22% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2183.643% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 54.699% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -47.704% |
Visgeneer Inc. | 158.6 Million TWD | 92.254% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 93.736% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 78.892% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 97.054% |
Sagittarius Life Science Corp | 13.32 Million TWD | 7.784% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 6.156% |
GlycoNex Incorporation | 900 Thousand TWD | -1265.111% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.578% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 91.49% |
PharmaEngine, Inc. | 14.8 Million TWD | 17.037% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.144% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 96.162% |
BiOptic Inc. | 93.19 Million TWD | 86.817% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 83.55% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -27.966% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -15.016% |
OBI Pharma, Inc. | 501.05 Million TWD | 97.548% |
Savior Lifetec Corporation | 270.37 Million TWD | 95.456% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 14.532% |
Level Biotechnology Inc. | 13.5 Million TWD | 9.006% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.378% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 63.906% |
Acepodia, Inc. | 273.81 Million TWD | 95.513% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 39.945% |